UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data shown on the profile page to:

http://www.ucl.ac.uk/finance/secure/research/post_award
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Dr Glenys Tennent
Wolfson Drug Discovery Unit
Centre for Amyloidosis & Acute Phase Proteins
UCL Division of Medicine, Royal Free Campus
London
NW3 2PF
Appointment
  • Senior Lecturer
  • Inflammation
  • Div of Medicine
  • Faculty of Medical Sciences
 
 
Research Summary

The research programme of the Wolfson Drug Discovery Unit, directed by Professor Sir Mark Pepys FRS, is highly collaborative and focused on development of effective therapies for treatment of amyloidosis and other major diseases associated with local amyloid deposition, and cardiovascular disease.

My current research efforts are focused principally on: (1) Thermodynamic characterisation of complexes formed between novel compounds and C-reactive protein (CRP), serum amyloid P component (SAP) or transthyretin (TTR), by isothermal titration and differential scanning calorimetry; (2) Characterisation of cellular mechanisms responsible for removal of amyloid in tissues of mice that receive novel treatment regimes; (3) Evaluation of ex vivo amyloid fibrils, and amyloid-like fibrils produced in vitro, for binding by anti-fibril antibodies and/or SAP, and other studies of amyloid fibril structure; (4) Evaluation of binding by novel compounds to amyloid deposits in situ in tissues of patients with systemic and hereditary amyloidoses. 

Academic Background
1995 PhD Doctor of Philosophy University of London
Please report any queries concerning the data shown on this page to:

https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by